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Multiple Sclerosis 
Background
The axon initial segment (AIS) is fundamental for neuronal
communication and action potential modulation, a
characteristic which has been shown to be disrupted in
inflammatory diseases such as Multiple Sclerosis. Previous
work has portrayed evidence of AIS breakdown in layer 5 of
the cortex, which was independent of demyelination in
experimental autoimmune encephalomyelitis (EAE) induced
mice. It has also been found that AnkyrinG, is an essential
cytoskeletal scaffolding protein necessary for proper AIS
function. It further promotes clustering of necessary AIS
proteins and voltage-gated sodium channels. AnkyrinG
deficiency results in a non-functional AIS. Therefore, AIS
stability is critical for neuronal function. Furthermore, in order
to determine if the pathology is specific to the cortex or affects
other regions of the brain in the EAE model, we investigated
the hippocampus, a region associated with cognitive
dysfunction in several inflammatory diseases.
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Figure 4. AISs are observed in the dentate gyrus (A,B) and CA1 (C,D) of the hippocampus. No
overt differences were observed in the number of AISs in these region between Naïve and EAE
mice. Quantitative analysis was inviable due to extensive overlapping and clustering of the
AISs (ankyrinG, red). Western blots of hippocampal homogenates from Naïve, Late EAE, and
Chronic EAE reveal no breakdown of Beta IV Spectrin (E).
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Figure 2. Mice are induced for EAE with an injection of MOG+CFA accompanied by pertussis
toxin. ~8 days post injection (dpi), mice show initial signs of disease; ~14 dpi mice reach peak
disease based on clinical symptoms, and analyses are conducted 3 (Early) and 9 (Late) days
post peak.
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Figure 1. MS brains (B) display significantly fewer AISs (C) than aged-matched 
non-MS brains (A). (ankyrinG, red)   p<0.05 
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Incidence: 2.3 million people worldwide 
diagnosed with MS
Immune-mediated disorder of the CNS 
where healthy myelin tissues are 
damaged 
Symptoms:
 Cognitive dysfunction 
 Visual disturbances 
Figure 3. Immunoreactivity against an ankyrinG antibody reveals robust labeling of AISs in
Layer V of the cortex of Naïve (A) and Early EAE mice (B). In Late EAE mice ankyrinG labeling
revealsa significant reduction in AISs (C-D). (ankyrinG, red) n ≥ 5 per group, p<0.05.
Demyelination, as assessed by MBP labeling (green), is not observed (E-G) in the cortex of EAE
mice illustrating AIS loss is independent of demyelination. Western blot run on Naϊve, Early
EAE, and Late EAE display Beta IV Spectrin breakdown in Late EAE at 75 kD (H).
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 Immunohistochemical (IHC) labeling for ankyrinG combined with laser confocal microscopy 
display an inefficient method of quantifying AISs in the hippocampus
 Preliminary data illustrates no breakdown of AISs in the hippocampus as observed in the 
cortex
 Western blots display Beta IV Spectrin breakdown in the cortex, but not in the 
hippocampus
 Microglial morphology in the cortex and hippocampus will be assessed to determine if a 
difference in activation results in AIS breakdown or preservation
 Microglia are enigmatic and are known to play different roles in different regions of the 
brain. Therefore,  we are interested in isolating these cells from the hippocampus and from 
the cortex to compare microglial expression profiles
 Findings from these studies should shed light on the role microglia play in different brain 
regions during disease.
